Search

You searched for " retina"

2073 results found

The treachery of images – making sense of OCT imaging

1 June 2016 | | EYE - Vitreo-Retinal, EYE - Imaging
In 1929 Belgian surrealist Rene Magritte produced his painting La Trahison des Images. It depicted an old fashioned pipe for smoking tobacco and underneath were the words “ceci n’est pas une pipe”, this is not a pipe. You may wonder...

Sustainability in eyecare: Intraocular gases and the climate emergency

4 August 2021 | | EYE - Vitreo-Retinal, EYE - General
In 2020 the NHS became the first national health system to commit to delivering ‘net zero’ carbon emissions by 2040. The author investigates how the impact of ophthalmic surgery can be reduced. Medical gases have been used in ophthalmic surgery...

Sclerochoroidal calcification masquerading as ocular malignancy

5 April 2022 | | EYE - Vitreo-Retinal, EYE - General
Case 1 A 68-year-old Caucasian gentleman was urgently referred to eye casualty by his optometrist after seeing an unusual incidental finding of protruding lesions from the retina, suspecting choroidal melanoma. He was asymptomatic and this was his first eye test...

A comparison of light sources in retinal imaging

1 October 2021 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Before starting to talk about the light sources present in retinal imaging, it is necessary to start from the base: the light. Light is an electromagnetic wave whose smallest part is the photon (or quantum of light). A high frequency...

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

5 February 2020 | | EYE - Vitreo-Retinal, EYE - General
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...

Treatment of diabetic macular oedema

1 June 2014 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

Inherited retinal disorders now the leading cause of blindness

1 April 2014 | | EYE - Vitreo-Retinal
The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...

Innovations in posterior uveitis: In conversation with Dr Colin Chu

1 July 2025 | | EYE - Imaging
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...

Cancer associated retinopathy

7 December 2020 | | EYE - Vitreo-Retinal, EYE - General
Abdul Muhyemin Tarin reviews the presentation, pathophysiology and management of this paraneoplastic syndrome. Case presentation A 60-year-old hypermetropic female patient presented with several months’ history of painless blurred vision. Visual acuity (VA) was 6/24 and 6/9-1 in right and left...

AI breakthrough in detecting leading cause of childhood blindness

3 May 2023 | AI, blindness, Children
An artificial intelligence (AI) tool could be an effective way of identifying retinopathy of prematurity (ROP), the leading cause of childhood blindness in middle-income countries, finds a new study led by UCL and Moorfields Eye Hospital researchers.

SCONe Project seeks participants for patient and public involvement group to revolutionise AMD research

29 April 2024 | baljean dhillon, SCONe, project, research, scotland, edinburgh, AMD, call to action
The SCONe project, run by optometrists, ophthalmologists, and researchers from the University of Edinburgh, and funded by Sight Scotland, is appealing for participants to take part in a Patient and Public Involvement (PPI) group focused on revolutionising the detection and management of Age-Related Macular Degeneration (AMD).

AI predicts eye damage from autoimmune drug, years before symptoms appear

1 September 2025 | artificial intelligence, hydroxychloroquine, pharmacology, research, Moorfields
A novel AI tool could transform screening for patients taking hydroxychloroquine by spotting early signs of eye damage, according to a study published in Opthalmology Retina. Researchers have devised an artificial intelligence (AI) system that can detect and predict serious...